When and how ruling out cystic fibrosis in adult patients with bronchiectasis

Multidisciplinary Respiratory Medicine
Andrea GramegnaFrancesco Blasi

Abstract

Bronchiectasis is the final result of different processes and most of the guidelines advocate for a careful evaluation of those etiologies which might be treated or might change patients' management, including cystic fibrosis (CF). CFTR mutations have been reported with higher frequency in bronchiectasis population. Although ruling out CF is considered as a main step for etiological screening in bronchiectasis, CF testing lacks of a standardized approach both from a research and clinical point of view. In this review a list of most widely used tests in CF is provided. Exclusion of CF is imperative for patients with bronchiectasis and CFTR testing should be implemented in usual screening for investigating bronchiectasis etiology. Physicians taking care of bronchiectasis patients should be aware of CFTR testing and its limitations in the adult population. Further studies on CFTR expression in human lung and translational research might elucidate the possible role of CFTR in the pathogenesis of bronchiectasis.

References

Jan 1, 1989·Annals of Clinical Biochemistry·J M Kirk, A Westwood
Jun 1, 1984·The Journal of Clinical Investigation·K Sato, F Sato
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·M C PasteurM T Keogan
Dec 14, 2004·American Journal of Respiratory and Critical Care Medicine·David M RodmanJerry A Nick
Sep 25, 2007·Chest·Yasmin YaakovMichael Wilschanski
May 30, 2008·Respiratory Research·Isabelle FajacThierry Bienvenu
Jun 23, 2009·The European Respiratory Journal·M P MurrayA T Hill
Jul 22, 2010·Thorax·M C PasteurUNKNOWN British Thoracic Society Bronchiectasis non-CF Guideline Group
Sep 22, 2010·The Medical Journal of Australia·Anne B ChangPaul J Torzillo
Sep 28, 2010·American Journal of Respiratory and Critical Care Medicine·Maeve P MurrayAdam T Hill
Jun 18, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·K De BoeckUNKNOWN EuroCareCF WP3 Group on CF diagnosis
Jun 17, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·C BombieriC Ferec
Jun 12, 2012·International Journal of Clinical Pharmacy·Rosana HernandoRamon Orriols
Aug 7, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Nadav TraegerAllen J Dozor
Sep 12, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Lutz NaehrlichUNKNOWN ECFS Diagnostic Network Working Group
Apr 5, 2014·Annals of the American Thoracic Society·Chee Y OoiPeter Durie
Mar 21, 2015·The European Respiratory Journal·James D ChalmersFrancesco Blasi
Aug 22, 2015·The European Respiratory Journal·Felix C RingshausenJessica Rademacher
Oct 3, 2015·Annals of the American Thoracic Society·Sara LonniStefano Aliberti
Oct 11, 2015·The European Respiratory Journal·Jessica RademacherBurkhard Tümmler
Feb 6, 2016·The European Respiratory Journal·Stefano AlibertiJames D Chalmers
Feb 10, 2016·Respiratory Medicine·James D ChalmersPieter Goeminne
Apr 3, 2016·The European Respiratory Journal·Daniel J Smith
Apr 6, 2016·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·W-J GuanN-S Zhong
Apr 15, 2016·The European Respiratory Journal·Stefano AlibertiUNKNOWN SIP Bronchiectasis Audit Working Group
May 4, 2016·Lancet·J Stuart Elborn
Jun 4, 2016·American Journal of Respiratory and Critical Care Medicine·Joseph M CollacoGarry R Cutting
Jun 12, 2016·The European Respiratory Journal·Stefano AlibertiUNKNOWN EMBARC Study Group
Jun 24, 2016·Science Translational Medicine·Johanna F DekkersJeffrey M Beekman
Jun 28, 2016·Annals of the American Thoracic Society·Miguel Á Martínez-GarcíaCasilda Olveira
Jul 18, 2016·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Gloria TridelloPaola Melotti
Oct 13, 2016·ERJ Open Research·James D ChalmersFrancesco Blasi
Nov 28, 2016·Respiratory Medicine·Mònica MonteagudoMarc Miravitlles
Nov 28, 2016·Chest·Timothy R AksamitUNKNOWN Bronchiectasis Research Registry Consortium
Jan 23, 2017·Respiration; International Review of Thoracic Diseases·Francesco AmatiStefano Aliberti
Jan 29, 2017·The Journal of Pediatrics·Philip M FarrellPatrick R Sosnay
Jan 29, 2017·The Journal of Pediatrics·Patrick R SosnayKris De Boeck
Jul 18, 2017·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·John J BrewingtonJohn P Clancy
Sep 11, 2017·The European Respiratory Journal·Eva PolverinoJames D Chalmers

❮ Previous
Next ❯

Citations

Aug 29, 2018·Multidisciplinary Respiratory Medicine·Stefano Aliberti, James D Chalmers
Mar 7, 2021·Diagnostics·Rita PadoanGiuseppe Campagna
Jul 15, 2021·Seminars in Respiratory and Critical Care Medicine·Francesco AmatiStefano Aliberti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.